Actigraphy is poor measure of eczema activity

November 5, 2012
Actigraphy is poor measure of eczema activity
The use of actigraphy to record movement as an objective surrogate for eczema activity is of limited use, according to a study published in the November issue of the British Journal of Dermatology.

(HealthDay)—The use of actigraphy to record movement as an objective surrogate for eczema activity is of limited use, according to a study published in the November issue of the British Journal of Dermatology.

Catriona I. Wootton, M.B., Ch.B., from Queen's Medical Centre in Nottingham, U.K., and colleagues collected accelerometer data from 336 participants in the Softened Water Trial to evaluate its validity as an objective measure of itch assessment in eczema. Data from actigraphy monitors were compared to three standardized scales: Six Area, Six Sign (SASSAD) severity score; Patient Oriented Eczema Measure (POEM); and Family Impact (DFI).

The researchers found that there was poor convergence of the validity of the accelerometer data with the other measures of eczema severity, with a correlation between the actigraphy and SASSAD of 0.15 (P = 0.02) and actigraphy and POEM 0.10 (P = 0.13). The correlation with the DFI was low on assessment for divergent validity against quality-of-life measures. Low, negative correlations were found when comparing the change scores from baseline to week 12 for SASSAD, POEM, and DFI with the change in scores. The meters were generally well tolerated.

"Actigraphy did not correlate well with or quality of life when used as an objective outcome measure in a multicenter clinical trial, and was not responsive to change over time," the authors write. "Further work is needed to establish why this might be, and to establish improved methods of distinguishing between eczema-related and eczema-nonrelated movements."

Explore further: Topical treatment shows potential for infantile eczema

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Topical treatment shows potential for infantile eczema

August 8, 2012
(HealthDay) -- Ten days of treatment with a cream containing 15(R/S)-methyl-lipoxin A4 (LXA4) is well tolerated and reduces the severity of infantile eczema, according to a study published online July 26 in the British Journal ...

Methotrexate and azathioprine equally efficacious for eczema

April 6, 2012
(HealthDay) -- Methotrexate and azathioprine may be equally effective in treating severe atopic eczema in adults, according to a critical appraisal of a study published in the April issue of the British Journal of Dermatology.

Sequential oral, topical tacrolimus benefits dermatitis

September 20, 2012
(HealthDay)—Sequential therapy with oral tacrolimus and topical tacrolimus may be an effective treatment for severe atopic dermatitis (AD), according to a pilot study published in the October issue of the Journal of the ...

Recommended for you

Pneumonia vaccine under development provides 'most comprehensive coverage' to date, alleviates antimicrobial concerns

October 20, 2017
In 2004, pneumonia killed more than 2 million children worldwide, according to the World Health Organization. By 2015, the number was less than 1 million.

Newly discovered viral marker could help predict flu severity in infected patients

October 20, 2017
Flu viruses contain defective genetic material that may activate the immune system in infected patients, and new research published in PLOS Pathogens suggests that lower levels of these molecules could increase flu severity.

H7N9 influenza is both lethal and transmissible in animal model for flu

October 19, 2017
In 2013, an influenza virus that had never before been detected began circulating among poultry in China. It caused several waves of human infection and in late 2016, the number of people to become sick from the H7N9 virus ...

Flu simulations suggest pandemics more likely in spring, early summer

October 19, 2017
New statistical simulations suggest that Northern Hemisphere flu pandemics are most likely to emerge in late spring or early summer at the tail end of the normal flu season, according to a new study published in PLOS Computational ...

New insights into herpes virus could inform vaccine development

October 18, 2017
A team of scientists has discovered new insights into the mechanisms of Epstein-Barr virus (EBV) infection, as well as two antibodies that block the virus' entry into cells. The findings, published in Proceedings of the National ...

Pair of discoveries illuminate new paths to flu and anthrax treatments

October 17, 2017
Two recent studies led by biologists at the University of California San Diego have set the research groundwork for new avenues to treat influenza and anthrax poisoning.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.